MedPath

TRIAZOLAM TABLETS 0.125MG

TRIAZOLAM TABLETS 0.125MG

Discontinued
DIN Number

02230024

Drug Class

Human

Market Date

Jan 3, 1997

Company
HC

prempharm inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02230024
AIG Number0112970001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD05 TRIAZOLAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

TRIAZOLAMActive
Strength: 0.125 MG
Monograph: TRIAZOLAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.